Supported by
14 October 2000: Responsibility to the Community
08:00 – 09:00 Registration and Coffee/Tea
Opening Session: (Chairs: Nelson Sewankambo and Daniel Wikler)
09:00 – 09:30
Welcome Nelson Sewankambo, Makerere Medical School, Uganda Daniel Wikler, World Health Organization, Switzerland
09:30 – 09:45
Health research, community benefit, and national development Natth Bhamarapravati, Centre For Vaccine Development, Mahidol University, Thailand
9:45 – 10:30
Health research and responsibility to the community Dr. Malegaparu Makgoba, Medical Research Council, South Africa Ruth Macklin, Einstein Medical College, USA
10:30 – 10:45 Coffee/Tea
Case Studies: Responsibility to the community (Chairs: Francois Hirsch and V. Mathan)
Case Studies: Responsibility to the community (Chairs: Francois Hirsch and V. Mathan)
10:45 – 11:15
Case Study 1: VaxGen AIDS Vaccine, Thailand Vichai Chokevivat, Ministry of Public Health, Thailand
11:15 – 11:45
Case Study 2: Drug Price Negotiation: Tropical Diseases Research, WHO, Juntra Karbwang, World Health Organization, Switzerland Howard Engers, World Health Organization, Switzerland
11:45 – 12:15
Case Study 3: “Good Neighbours”: Developing an Ethical Paradigm for Community- Based Studies (Video Presentation) Geoff Solarsh, Africa Centre for Population and Reproductive Health Research, South Africa
12:15 – 13:30 Lunch
13:30 – 15:30
Group discussion of case studies and preparation of reports (Coffee/Tea available)
15:30 – 16:00 Reports from groups on case studies
Community Benefit and Justice (Chairs: Bebe Loff and Ju Zhang)
16:00 – 17:30
Perspectives on community benefit agreements, development, and justice Heng Leng Chee, University Putra Malaysia, Malaysia José Esparza, World Health Organization, Switzerland Reidar Lie, University of Bergen, Norway John Horton, SmithKline Beecham, UK
17:30 – 18:00
Working Group on Community Benefit Agreements Wen Kilama, African Malaria Vaccine Testing Network, Tanzania Vasantha Muthuswamy, Indian Council of Medical Research, India Partha Majumder, Indian Statistical Institute, India Jack Killen, National Institute of Allergy & Infectious Diseases, NIH, USA
18:30 Reception (with informal dinner)
15 October 2000: Capacity Building
08:00 – 09:00 Coffee/Tea
Building Capacity for Ethical Review (Chairs: Robert Cook-Deegan and Daphna Feinholz-Klip)
08:30 – 09:00
What constitutes capacity for ethical review; Zulfiqar Bhutta, The Aga Khan University, Pakistan
9:00 – 10:15
Current initiatives in capacity building in bioethics in research Forum for Ethical Review Committees in the Asian and Western Pacific Region (FERCAP):
10:15 – 10:30
Developing country perceptions of sponsor requirements for ethical review; Adnan Hyder, Health Services Academy, Pakistan
10:30 – 10:45 Coffee/Tea
10:45 – 12:00
Group work on:
12:00 – 13:30 Lunch
Global Strategy on Bioethics Capacity Building (Chairs: Richard Cash and José Esparza)
13:30 – 14:30
Formation of a strategy on co-ordination of capacity building in ethical review of health research involving human subjects: Group Reports and Discussion
14:30 – 15:00
Establishment of a Working Group on Co-ordination of Capacity Building in Ethical Review of Health Research involving Human Subjects.
Open Discussion
15:00 – 15:30 Coffee/Tea
15:30 -16:00
Update: Revisions of Declaration of Helsinki and CIOMS Guidelines Juhana Idänpään-Heikkila, Council for International Organizations of Medical Sciences (CIOMS), Switzerland Seamus Gallagher, CIOMS, Switzerland The Role of the Global Forum on Bioethics in Research (Chairs: Gerald Keusch and Wen Kilama)
16:00 – 17:00
Business meeting of the Global Forum on Bioethics in Research
17:00 – 17:30
Summary and preview of future Forums Malcolm Clarke, The Gambian Government Ethics Committee, Gambia Imogen Evans, Medical Research Council, UK Maarten Schim van der Loeff, Medical Research Council, UK/Gambia
17:30 Forum Concludes